Meditation smartphone application effects on prehypertensive adults' blood pressure: Dose-response feasibility trial
Zachary W Adams, John C Sieverdes, Brenda Brunner-Jackson, Martina Mueller, Jessica Chandler, Vanessa Diaz, Sachin Patel, Luke R Sox, Spencer Wilder, Frank A Treiber, Zachary W Adams, John C Sieverdes, Brenda Brunner-Jackson, Martina Mueller, Jessica Chandler, Vanessa Diaz, Sachin Patel, Luke R Sox, Spencer Wilder, Frank A Treiber
Abstract
Objective: Essential hypertension (EH) is the most common chronic disease in the United States and a major cause of morbidity and mortality. Lifestyle interventions (e.g., diet, exercise, stress management) to reduce blood pressure (BP) are often complex with varying effectiveness. Breathing awareness meditation (BAM) is a stress management strategy with encouraging effects on BP, though widespread dissemination is hampered by the lack of an easy-to-use methodology to train and monitor BAM practices. A smartphone application (Tension Tamer [TT]) that implements BAM and tracks adherence has shown promise in addressing these gaps. This 6-month dose-response feasibility trial evaluated effects of the app on BP to further optimize BAM user guidelines.
Methods: Sixty-four adults with prehypertension were randomized to complete TT-guided BAM sessions for 5-, 10-, or 15-min intervals twice daily over 6 months. Continuous heart rate readings derived from the phone's video camera via reflective photoplethysmography were used as feedback and as an index of time-stamped adherence. Outcomes (resting BP, HR) were collected at baseline, 1-, 3-, and 6-months.
Results: Mixed modeling results showed a significant time effect for systolic BP (SBP) with a dose-response effect at Months 3 and 6. Adherence declined over time and was lowest in the 15-min dose condition, though SBP reductions were maintained. Generally, adherence was negatively associated with dose as the study progressed.
Conclusions: Smartphone-implemented BAM appears to reduce SBP and can be a low-cost method to reach large populations. (PsycINFO Database Record
Trial registration: ClinicalTrials.gov NCT03168789.
Conflict of interest statement
No conflicts of interested from any authors were declared.
(c) 2018 APA, all rights reserved).
Figures
Source: PubMed